Skip to content

Search

Why RNA?
Doug Hughes, Neotract

“The RNA team is great. Sam and Kayvon have done an exceptional job working with my companies for over a decade. They deliver on time and I don’t have to spend time getting them up to speed because they already know healthcare and medtech.”

Meet The Team

What Our Clients Say

Board of Advisors

Referral Networks & Partners

Join the RNA Team
Who We Advise
Misti Ushio, Digitalis Ventures

“RNA is always great to work with. They’re smart, they work fast, and they can jump in and get up to speed quickly. When we had critical needs, they’ve been able to really help us out in tough spots.”

Venture-Backed Private Companies

Public Companies

Investors

Healthcare Systems & Universities

Executives
Sectors
Stig Hansen, Kimia Therapeutics

“I’ve worked with the RNA team for over a decade across my current and previous companies. They are our go to valuation firm for valuation because they know the industry, are responsive and understand the nuances that drive transactions just as much as accounting.”

Biopharmaceuticals

Medtech

Digital Health

Healthcare Services

Technology
What We Deliver

VALUATION OPINIONS

Fairness Opinions

Portfolio Valuation Opinions

Strategic Valuation Opinions

Financial Reporting Valuation Opinions

Tax Reporting Valuation Opinions

TRANSACTION ADVISORY

Benchmarking, Modeling and Analytic Services

Buy-Side Due Diligence & Transaction Support

Sell-Side Due Diligence & Transaction Support

M&A Advisory

Licensing and Partnering Advisory

STRATEGIC ADVISORY

Corporate Strategy

Target Identification and Portfolio Planning

Pricing and Market Access

Market Research and Analysis

Forecasting, Modeling and Simulation
Stories

Client Success Stories

Exploring Multiple Strategic Options: A Multi-Track Process

Due Diligence Support (Buy-Side): Fund Manager

Portfolio Modeling Supporting a Financing Transaction

View More
Insights

Latest RNA Insights

We Were Promised a Singularity. What We Need Is Integration.

Why We Wrote It: The Origin of Our Complexity-Informed Framework

Why Linear Valuation Models Fail in Life Sciences

Read More
Contact

Contact Us

David Chacko, Erasca

“The RNA team is responsive and efficient and understands the nuances of valuation as pertains to our sector, and we valued our partnership with them.”

Why RNA?
Who We Advise
Sectors
What We Deliver
Stories
RNA Insights
Contact

Why RNA?
Who We Advise
Sectors
What We Deliver
Stories
RNA Insights
Contact

Contact

Let's Talk!

Name

Company

Phone

Email

Message

I HAVE READ AND AGREE TO THE PRIVACY POLICY.

Mailing Address

2195 South Virginia Street
Reno, NV 89502

Phone

833-421-1159

Email

info@rnaadvisors.com

Sign Up for Our Newsletter:

Name

Email

Phone: 833-421-1159

Email: info@rnaadvisors.com

Search

Why RNA?
Who We Advise
Sectors
What We Deliver
Stories
RNA Insights
Contact

© 2026 RNA Advisors, LLC. All rights reserved. | Disclaimers | Privacy Policy | Site by CreativePickle.

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.

First Name

Last Name

Email